STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 12th, 2020 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
Contract Type FiledAugust 12th, 2020 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is made and entered into as of August 9, 2020, by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jubilant Draximage Inc. dba Jubilant Radiopharma, Radiopharmaceuticals Division, a corporation incorporated under the laws of Canada (the “Investor”).